Chronic disease treatment advances add to U.S. health care bill

Advances in treatments for diabetes and many other chronic illnesses may have reduced hospitalizations, but their cost may be even higher than that of treating acute events. The few makers of supplies and drugs for Type 1 diabetes have considerable market power, and doctors say some advances, such as "talking" blood glucose meters, are not worth the cost.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT